Back to top
more

VanEck Biotech ETF: (BBH)

(Delayed Data from NASDAQ) As of Jul 11, 2025 03:59 PM ET

$158.32 USD

158.32
10,761

-2.82 (-1.75%)

Volume: 10,761

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $158.25 -0.07 (-0.04 %) 7:58 PM ET

ETF Quote Details

Previous Close 161.14
Open 159.77
Bid 155.47
Ask 161.31
Day Low-High 158.04-159.77
52wk Low-High 135.34-183.64
Volume 10,761
NAV (month end) 153.32
Premium (+)/Discount (-) (month end)+7.82

Zacks Premium Research for BBH

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

High
ETF Research Report

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $1.25 (0.79%)
Issuer VAN ECK

Benchmark for BBH

MVIS US LISTED BIOTECH 25 INDEX

The MVIS US Listed Biotech 25 Index tracks the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment.

Fund Summary for BBH

VANECK BIOTECH ETF

The VanEck Biotech ETF replicates as closely as possible, before fees and expenses, the price and yield performance of MVIS US Listed Biotech 25 Index.